These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12599930)

  • 41. [Recent changes in the management of advanced non-small cell lung cancer].
    Kodama N; Kawahara M; Furuse K
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2564-70. PubMed ID: 7979414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paclitaxel and carboplatin as neoadjuvant chemotherapy in operable (stage I and II) and locally advanced (stage IIIA-N2) non-small cell lung cancer.
    Splinter TA
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):59-61. PubMed ID: 9007124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjuvant treatment in resected non-small cell lung cancer: current and future issues.
    Remon J; Lianes P; Martínez S; Velasco M; Querol R; Zanui M
    Crit Rev Oncol Hematol; 2013 Nov; 88(2):375-86. PubMed ID: 23809199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality assurance of thoracic radiotherapy in EORTC 08941: a randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapy.
    Kramer GW; Legrand CL; van Schil P; Uitterhoeve L; Smit EF; Schramel F; Biesma B; Tjan-Heijnen V; van Zandwijk N; Splinter T; Giaccone G; van Meerbeeck JP;
    Eur J Cancer; 2006 Jul; 42(10):1391-8. PubMed ID: 16785054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer. A phase II trial conducted by the Groupe Francais de Pneumo-Cancerologie (GFPC).
    Vergnenègre A; Daniel C; Léna H; Fournel P; Kleisbauer JP; Le Caer H; Letreut J; Paillotin D; Pérol M; Bouchaert E; Preux PM; Robinet G;
    Lung Cancer; 2005 Mar; 47(3):395-404. PubMed ID: 15713523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Phase III studies of combined chemotherapy and radiation in locally advanced non-small-cell lung cancer and limited small-cell lung cancer].
    Kawahara M
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):335-40. PubMed ID: 7880104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evolution of combined modality therapy for stage III non-small-cell lung cancer.
    Gandara DR; Edelman M; Lara P; Roberts P; Leigh B
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):35-41. PubMed ID: 10981289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ACR Appropriateness Criteria® postoperative adjuvant therapy in non-small cell lung cancer.
    Decker RH; Langer CJ; Rosenzweig KE; Chang JY; Gewanter RM; Ginsburg ME; Kong FM; Lally BE; Videtic GM; Movsas B
    Am J Clin Oncol; 2011 Oct; 34(5):537-44. PubMed ID: 21946673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions.
    Bunn PA
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-153-S12-162. PubMed ID: 9331142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer.
    Stephens RJ; Girling DJ; Hopwood P; Thatcher N;
    Lung Cancer; 2005 Sep; 49(3):395-400. PubMed ID: 15908042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimal therapy for unresectable stage III non-small-cell lung cancer.
    Vokes EE
    J Clin Oncol; 2005 Sep; 23(25):5853-5. PubMed ID: 16087940
    [No Abstract]   [Full Text] [Related]  

  • 53. Multimodality therapy for non-small cell lung cancer (NSCLC): ongoing Italian experiences in the adjuvant and neoadjuvant settings.
    Crinò L; Cappuzzo F
    Lung Cancer; 2001 Dec; 34 Suppl 3():S45-7. PubMed ID: 11740993
    [No Abstract]   [Full Text] [Related]  

  • 54. Management of unresectable non-small cell carcinoma of the lung (NSCLC).
    Cox JD; Le Chevalier T; Arriagada R; Choy H; Curran WJ; Fukuoka M; Harper P; Komaki R; Le Pechoux C; Lievens Y; Rami-Porta R; Ready N; Sause W; Stuschke M; Thatcher N
    Lung Cancer; 2003 Dec; 42 Suppl 1():S15-6. PubMed ID: 14708518
    [No Abstract]   [Full Text] [Related]  

  • 55. The role of radiotherapy in non-small-cell lung cancer.
    Senan S; Lagerwaard FJ
    Ann Oncol; 2005; 16 Suppl 2():ii223-8. PubMed ID: 15958462
    [No Abstract]   [Full Text] [Related]  

  • 56. Chemotherapy and non-small-cell lung cancer.
    Drug Ther Bull; 2002 Feb; 40(2):9-11. PubMed ID: 11892374
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Review of the curative role of radiotherapy in the treatment of non-small cell lung cancer.
    Damstrup L; Poulsen HS
    Lung Cancer; 1994 Sep; 11(3-4):153-78. PubMed ID: 7812695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined modality therapy for non-small cell lung cancer, past, present, and future.
    Kim DW; Choy H
    Lung Cancer; 2003 Dec; 42 Suppl 2():S35-40. PubMed ID: 14644534
    [No Abstract]   [Full Text] [Related]  

  • 59. Lung cancer. 4: chemotherapy for non-small cell lung cancer: the end of the beginning.
    Cullen M
    Thorax; 2003 Apr; 58(4):352-6. PubMed ID: 12668803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined modality therapy for unresectable non-small cell lung cancer.
    Sause WT
    Lung Cancer; 2003 Dec; 42 Suppl 2():S47-51. PubMed ID: 14644536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.